Literature DB >> 10575148

Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit.

A B Hoyos1.   

Abstract

OBJECTIVES: Necrotizing enterocolitis (NEC) has been associated with a wide variety of bacteria and their cytotoxins. The content and the nature of gut bacterial colonization in newborns that require intensive care hospitalization has been demonstrated to be abnormal. In the 25-bed neonatal intensive care unit in Hospital Simon Bolivar, in Bogotá, Colombia, cases of NEC are common causes of morbidity and mortality. This article examines the hypothesis that oral administration of prophylactic Lactobacillus acidophilus and Bifidobacterium infantis to all neonates in an intensive care unit, would decrease the incidence of NEC.
METHODS: Daily doses of 250 million live L. acidophilus and 250 million B. infantis were given to all 1237 newborns (both inpatients and transfer patients) admitted to the unit during 1 year, until they were discharged from the hospital. In this study, 1282 patients hospitalized during the previous year were used as controls.
RESULTS: There were no complications attributed to the daily administration of L. acidophilus and B. infantis. The study groups were compared for place of origin, clinical, and demographic variables, and there was no statistically significant difference in those variables. In the historic control group, there were 85 NEC cases compared to 34 cases in the group that received probiotic prophylaxis (P < 0.0002). In the historic control group, there were 35 NEC-associated fatalities compared to 14 fatalities in the group that received probiotic prophylaxis (P < 0.005).
CONCLUSIONS: The positive results in this study support the need for further investigation of bacterial colonization and its role in NEC.

Entities:  

Mesh:

Year:  1999        PMID: 10575148     DOI: 10.1016/s1201-9712(99)90024-3

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  70 in total

Review 1.  Immunonutrients and neonates.

Authors:  Ying Huang; Xiao Mei Shao; Josef Neu
Journal:  Eur J Pediatr       Date:  2003-01-31       Impact factor: 3.183

Review 2.  Probiotics and necrotizing enterocolitis.

Authors:  Paul Fleming; Nigel J Hall; Simon Eaton
Journal:  Pediatr Surg Int       Date:  2015-09-21       Impact factor: 1.827

Review 3.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant.

Authors:  Kannikar Vongbhavit; Mark A Underwood
Journal:  Clin Ther       Date:  2016-02-09       Impact factor: 3.393

4.  Probiotics and necrotising enterocolitis in premature infants.

Authors:  R J Schanler
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

5.  A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids.

Authors:  Mark A Underwood; Nita H Salzman; Stephen H Bennett; Melissa Barman; David A Mills; Angela Marcobal; Daniel J Tancredi; Charles L Bevins; Michael P Sherman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

6.  Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Monica Williams; Mikael Petrosyan; Yigit Guner; Rahul Mittal; Dennis Mock; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

7.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec

Review 8.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 9.  Microecology, intestinal epithelial barrier and necrotizing enterocolitis.

Authors:  Renu Sharma; Joseph J Tepas
Journal:  Pediatr Surg Int       Date:  2009-12-05       Impact factor: 1.827

Review 10.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.